Catalog No.
PHB89101
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human ASS1 (Glu149-Lys412).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
ASS1, Citrulline--aspartate ligase, Argininosuccinate synthase, ASS
Concentration
1.53 mg/ml
Purification
Purified by antigen affinity column.
Accession
P00966
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
[Morphomolecular subtyping of hepatocellular adenoma]., PMID:40471284
Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer's Disease., PMID:40309797
The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis., PMID:37536037
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment., PMID:36356191
Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance., PMID:36201426
ASS1 regulates immune microenvironment via CXCL8 signaling in ovarian cancer., PMID:36182868
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion., PMID:35782058
A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma., PMID:35466524
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors., PMID:34841717
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer., PMID:34382365
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies., PMID:33674736
Arginine metabolism: a potential target in pancreatic cancer therapy., PMID:33395072
Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling., PMID:31522975
A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma., PMID:30796035
Transcriptome of porcine alveolar macrophages activated by interferon-gamma and lipopolysaccharide., PMID:30086883
Gene expression in the chicken caecum is dependent on microbiota composition., PMID:29202873
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial., PMID:27584578
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines., PMID:25611858
Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer., PMID:22714882
Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice., PMID:15364459
For research use only. Not for human or drug use.
